News

From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...
Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.
Researchers at the University of Western Australia examined the implications of architectural design on health facilities, ...